13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001608126
Total reported value
$2.8B
$2.8B
9 檔
69.7%
At the close of Q1 2026, Finepoint Capital LP disclosed equity holdings valued at approximately $2.8B, spread across 9 reported holdings.
Finepoint Capital LP executed strategic sector rebalancing during Q1 2026, establishing 2 new positions while fully exiting 2 holdings and trimming 2 positions.
In terms of portfolio concentration, the top 5 core holdings (including SPY, SOXX, QQQ) accounted for 69.7% of total reported equity market value during Q1 2026.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 35.13% | +10.54% | -32.96% | |
| 2 | SOXX | Ishares Semiconductor ETF | ETF-Other | 24.74% | -24.74% | EXIT | |
| 3 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 18.76% | -2.06% | — | |
| 4 | QXO | Qxo Inc | Stock-Industrials | 13.78% | -2.60% | -34.56% | |
| 5 | RXO | Rxo Inc | Stock-Other | 7.54% | -2.26% | +7.29% | |
| 6 | ANNAW | Aleanna Inc - Cl A - 29 | Stock-Other | 0.02% | -0.01% | — | |
| 7 | ANNA | Aleanna Inc | Stock-Other | 0.01% | -0.01% | — | |
| 8 | ✓ | Moneyhero Limited | Stock-Other | — | — | — | |
| 9 | CLDI | Calidi Biotherapeutics Inc | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RXO | Rxo Inc | +1.6% | +7.29% | Add |
| 2 | ANNAW | Aleanna Inc - Cl A - 29 | 0% | — | Unchanged |
| 3 | ANNA | Aleanna Inc | 0% | — | Unchanged |
| 4 | ✓ | Moneyhero Limited | — | — | Unchanged |
| 5 | CLDI | Calidi Biotherapeutics Inc | — | — | Unchanged |
| 6 | QXO | Qxo Inc | -6.6% | -34.56% | Trim |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | -18.4% | -32.96% | Trim |
| 8 | SOXX | Ishares Semiconductor ETF | — | NEW | New buy |
| 9 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
| 10 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 11 | SLDB | Solid Biosciences Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Finepoint Capital LP reported a total U.S. public equity portfolio value of $2.8B across 9 disclosed positions in Q1 2026.
During Q1 2026, Finepoint Capital LP's top holdings by market value included SPY (35.1%)、SOXX (24.7%)、QQQ (18.8%). The largest single position, SPY, represented 35.1% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
SOXX
市值: $483.1M
Top Position Liquidated / Trimmed
IWM
前期市值: $398.0M
In Q1 2026, Finepoint Capital LP made 7 total portfolio adjustments, initiating 2 new buys, adding to 1 positions, trimming 2 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.